Ex head of Laboratoire d'explorations fonctionnelles hôpital Necker-Enfants malades
BIOGRAPHY
DEC 06, 2018 6:00 AM CET
Overview of the main hormones associated with alteration of bone and mineral metabolism in patients with chronic kidney disease
Speaker
Event Date & Time
DATE: December 6, 2018
TIME: 6:00am PST, 9:00am EST, 3:00pm CET
Abstract
Alterations in the bone and mineral metabolism is of great concern in patients with chronic kidney disease (CKD). As the glomerular filtration rate (GFR) decreases, phosphatemia tends to increase while the renal secretion of the active vitamin D metabolite decreases with, consequently, increases in both serum PTH and FGF23 levels. This the pathophysiological basis of the so-called CKD-bone and mineral disorders (MBD). Experts in Nephrology have published international guidelines, called the KDIGO/CKD-MBD, to help the colleagues to deal with these disorders. In this webinar, the KDIGO recommendations concerning the measurement of the serum concentration of PTH, vitamin D metabolites and FGF23 will be discussed.
Learning Objective:
- Understand the bone metabolic disorder in CKD patients
- Which is the mechanism that regulate the calcium and phosphorus absorption in patient with altered hormone activities
- Know the utility of a few fundamental markers to decide the CKD patient management
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 06, 2018 6:00 AM CET
Share
Overview of the main hormones associated with alteration of bone and mineral metabolism in patients with chronic kidney disease
Loading Comments...